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Edited by Francesc PosasAbstract Increased plasminogen activator inhibitor-1 (PAI-1)
activity is associated with greater risk of myocardial infarction.
PAI-1 expression is regulated by a 4G/5G promoter polymor-
phism. The 4G allele is associated with higher PAI-levels and
greater circadian variation. Here we show that clock protein het-
erodimers BMAL/CLOCK cause greater activation (2-fold,
P < 0.05) of the 4G allele. Site-directed mutagenesis studies sug-
gest that clock genes act on two canonical E-boxes to regulate
PAI-1 promoter activity. These results identify a potential novel
mechanism whereby allele-speciﬁc clock genes – mediated mod-
ulation of PAI-1 expression may contribute to circadian varia-
tion in cardiac risk.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Plasminogen activator inhibitor-1 (PAI-1) is the major
inhibitor of ﬁbrinolysis [1]. Elevated plasma PAI-1 levels have
been shown to be associated with increased risk of recurrent
myocardial infarction (MI) [2]. Circulating PAI-1 levels are
under genetic control. In this regard, an insertion/deletion
(5G/4G) polymorphism at position 675 of the PAI-1 pro-
moter has been extensively studied [1]. The 4G allele of PAI-
1 is associated with increased plasma levels [3–7]. Circulating
PAI-1 levels also shows circadian variation, with increased lev-
els in the early morning, coinciding with the early morning
peak in risk of MI. Many circadian rhythms are regulated di-
rectly by an endogenous clock system, which is highly con-
served in organisms as diverse as cyanobacteria, plants, fruit
ﬂies, and mammals [8–10]. The mammalian timing system con-
sists of a set of ‘‘clock genes’’ that display circadian rhythms of
expression which in turn regulate the expression of output
genes. The model that has emerged is one of interlocking tran-
scriptional/translational feedback loops with positive and neg-
ative clock genes. The positive genes include Clock, Bmal1,
Bmal2, and Npas2, and the negative regulators are Per1-2,
Cry1-2 and Dec1-2 [10]. The CLOCK protein forms a hetero-*Corresponding author. Fax: +44 116 287 5792.
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and activate the promoters of genes under circadian control,
via a DNA element termed an E-box (CACGTG) [10]. Inter-
estingly, recent studies have shown that circadian variation
in PAI-1 activity is predominantly conﬁned to the 4G allele,
whereas 5G homozygotes do not display diurnal diﬀerences
in PAI-1 expression [5,6]. In this study we have characterised
the interaction of clock gene products with the PAI-1 pro-
moter and show that the degree of activation is allele speciﬁc.2. Materials and methods
Individuals were identiﬁed that were homozygous for either the 4G
or 5G allele from our human sample DNA bank. Fragments of the hu-
man PAI-1 5 0-ﬂanking region [796 to +140, relative to the transcrip-
tion start point (TSP)] were ampliﬁed by PCR from each allele using
primers 796F 5 0-GTACCATTGGGACCAGGGC-30 and 140R 5 0-
AGTCCATCCTCTTTTCGTTTG-3 0. This fragment contains all of
the reported deﬁnite and putative hypoxia-responsive element (HRE)
motifs in the promoter at positions 675 (CACGTG), 560 (CAC-
GTG), 453 (CACGTT), 197 (CACTGA), and 154 (CACATG)
[11] and also includes the whole of the 5 0-untranslated region
(UTR). Both of the HRE sites at 675 and 560 are canonical E-
Boxes and are termed E-box1 and E-box2 respectively. DNA frag-
ments were then subcloned into the luciferase reporter, pGL3-Basic.
PAI-1 promoter-reporter constructs with individual mutated HREs
(in 4G background) were kindly provided by Dr T. Fink [11]. Authen-
ticity of all plasmids were conﬁrmed by sequencing. Expression plas-
mids of human BMAL1, BMAL2, and CLOCK were kindly
provided by Dr J. Hogenesch and mouse CRY2 by Dr D. Weaver.
COS-7 cells were maintained in modiﬁed DMEM media containing
10% FCS and plated (at 50% conﬂuency) 24-h prior to transfection.
Reporter plasmids (100 ng/well) were co-transfected with 200 ng of
each expression plasmid or 200 ng of empty vector as control using
Jet-PEI transfection reagent. In addition 10 ng/well of pRL-null
Renilla luciferase plasmid was co-transfected as a control for transfec-
tion eﬃciency. Each experiment was performed in triplicate and re-
peated at least three times. To simulate a 4G/5G heterozygous
background 50 ng of each reporter was mixed and the resulting
100 ng used for the transfections. Reporter activities were measured
at 48 h post-transfection using a dual-luciferase reporter assay system
(Promega) and the results adjusted for Renilla values and then standar-
dised to the empty vector control. The values are expressed as mean-
s ± S.E.M. The signiﬁcance of diﬀerences between groups was
determined by Student t-test for paired values.3. Results
Co-transfection assays indicated that clock protein hetero-
dimers (BMAL1/CLOCK or BMAL2/CLOCK) can activate
the human PAI-1 promoter-reporter in vitro (Fig. 1). Theblished by Elsevier B.V. All rights reserved.
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Fig. 1. Transcriptional activation of the human PAI-1promoter by
clock proteins. Co-transfection analysis with clock protein heterodi-
mers BMAL1/CLOCK and BMAL2/CLOCK using PAI-1 5G (A), 4G
(B) and 5G/4G (C) allelic reporters. Each experiment was performed in
triplicate and each analysis includes the results of at least three
independent experiments. Error bars represent S.E.M. *P < .05 versus
5G BMAL1/CLOCK (n = 3); **P < .005 versus 5G BMAL2/CLOCK
(n = 6); #P < .005 versus 4G BMAL2/CLOCK (n = 3).
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BMAL2 was a stronger activator (approximately three times
as potent) than BMAL1 for both alleles (P < 0.05). Of par-
ticular importance, both BMAL1/CLOCK and BMAL2/
CLOCK heterodimers activated the PAI-1 4G allele reporter
more strongly (by 193 ± 13% and 203 ± 25%, respectively,
P < 0.05) than the 5G allele (Figs. 1A and B). Simulated
4G/5G heterozygote-reporter activity was similar to the 5G
allele reporter (Fig. 1C).
To elucidate the contribution of each putative HRE to the
BMAL2/CLOCK induced promoter activity, co-transfection
experiments were carried out using site-directed mutated
reporters. Mutation of the HRE at position 197 bp had no
eﬀect on clock gene activation of the PAI-1 promoter
(Fig. 2). However, mutation of E-box1 (675 bp) decreased
clock gene transactivation by 70%, and mutation of E-box2
(560 bp) reduced activity by 90%.4. Discussion
In this study we show that clock protein heterodimers acti-
vate the PAI-1 promoter, and more importantly, that this acti-
vation is allele speciﬁc which provides a potential explanation
for the circadian variation in plasma PAI-1 levels in subjects
with the 4G allele and not those with the 5G allele [5,6]. A pre-
vious study reported no preference for clock gene activation at
the 4G/5G allele, when transfected into bovine endothelial cells
[12]. The discrepancy may be due to the diﬀerence in the trans-
fection conditions. Schoenhard et al. [12] serum-starved their
cells for the latter 24 h (of the 48 h period). Serum-deprivationcan cause cellular stress and alters gene expression. Speciﬁ-
cally, serum-starvation directly modulates E-box driven activ-
ity in endothelial cells [13,14], and this could have aﬀected the
results obtained previously [12]. Schoenhard et al. [12] also
used reporters with only half (+72 bp) of the 5 0-UTR, whereas
we have used the full-length (+140 bp). This extra leader se-
quence contains several putative binding sites for factors such
as delta EF1 and Ets-1, which are absent in the +72 bp frag-
ment. Such factors have been shown to mediate both E-box
driven gene expression and to speciﬁcally activate PAI-1
expression [15,16]. It is therefore also possible that the diﬀerent
ﬁndings in the two studies are due to the diﬀerent lengths of the
5 0-UTR fragment used. In support of this, Kondratov et al.
[17] have recently reported that Ets-1 protein can act in concert
with clock proteins in the activation of another central clock
factor, Cry-1 in vitro [17]. Collectively, these data suggest the
existence of a gene network between Ets-1 and clock proteins
that regulate clock-output genes and circadian processes.
We have also characterised the nature of the interaction
between clock genes and the PAI-1 promoter. Previous stud-
ies have shown that other E-box containing promoters also
have a preference for BMAL2 containing herterodimers
[18], although the mechanism for this remains to be eluci-
dated. Our results demonstrate that not only can clock pro-
teins distinguish between E-box-like sequences (CACGTG
versus CACGTA) but also between apparent identical palin-
dromic E-boxes (E-box1 and E-box2) in the PAI-1 pro-
moter. The latter may be due to the immediate 3 0 ﬂanking
sequence, which is ‘‘G’’ for E-box1 and ‘‘A’’ for E-box2.
Hogenesch et al. [18] have demonstrated that clock protein
heterodimers have a preference for E-boxes with ﬂanking re-
gion speciﬁcity for an 3 0 ‘‘A’’ and this may explain the great-
er eﬀect on activation by clock protein heterodimers we
observed with disruption with E-box2. Since mutation of
either E-box caused a major disruption of activation, our re-
sults suggest transcriptional cooperation between the two E-
boxes. We propose that E-box2 (and to some extent E-box1)
determines the overall level of PAI-1 gene expression, but E-
box1 (coupled with the adjacent 4G/5G polymorphism)
drives, at least in part, the circadian expression of PAI-1
activity in humans.
The 5 0-sequence to E-box2 (known as the 3-bp spacer, 5 0-
AATCACGTG) is also essential for TGFb activation of
PAI-1 gene expression, and mutation of E-box2 abolishes the
TGFb-induced transcription of the human PAI-1 gene [19].
This might explain the diﬀerential binding capacity of clock
protein heterodimers to these two canonical E-boxes, and pro-
vides a further level of human PAI-1 regulation. Interestingly,
several recent reports have demonstrated that stimuli such as
interleukin-1, very low density lipoproteins, and angiotensin
II increase PAI-1 expression in vitro preferentially via the
4G allele [3,20,21], suggesting a possible interaction between
clock genes and these stimuli.
Further support for the regulation of PAI-1 by clock genes
comes from rodent studies. A diurnal expression of PAI-1
mRNA exists in the mouse heart, which reﬂects a similar
rhythm in plasma PAI-1 activity: these rhythms are abolished
in the Clock mutant mouse [22,23]. Of interest, inspection of
the mouse and rat PAI-1 proximal promoter reveals a con-
served canonical E-box (CACGTG) located at bp 179/
174 and 190/185, respectively, relative to the TSP.
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Fig. 2. Palindromic E-boxes confer high-level activation of the human
PAI-1 promoter by BMAL2/CLOCK heterodimers. Co-transfection
analysis using diﬀerent point mutated 4G PAI-1 promoter-reporter
and clock proteins. In the control (Con) experiments using the intact
full length PAI-1 reporter, the Luc activity was set to 100%. DHRE,
mutated HRE at position 197 bp; DEB1, mutated E-box1 at
675 bp; DEB2, mutated E-box2 at 560 bp. #P > .05 versus Con;
*P < .005 versus Con. N = 3 independent experiments determined in
triplicate. Error bars represent S.E.M.
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Myocardial infarction shows a signiﬁcant diurnal variation
with a surge in risk in the early morning [24]. Although the
overall contribution of the 4G/5G polymorphism to plasma
PAI-1 levels has been estimated to be relatively small [7],
our results, nonetheless, suggest that increased circadian
expression of the 4G allele due to its enhanced interaction
with clock proteins could contribute to the surge in MI risk
in the early morning [24]. This could in turn explain the re-
ported associations between both plasma PAI-1 level and
the 4G/5G polymorphism with risk of MI [4–6,25]. As such
this would be one of the ﬁrst examples of allele-speciﬁc clock
gene mediated activation of an output gene that could
contribute to disease.
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